Toggle

A reduced-intensity preparative regimen, called SUN, before allogeneic (cells from a donor) blood or marrow transplant (BMT) to treat sickle cell disease (SCD) in children, teens and young adults

Print

2 - 25

Phase 2

5 Locations

NCT03587272

Clinical Trial Goal


To find out if the SUN regimen before allogeneic BMT with a matched related donor is safe and works well to treat SCD in children, teens and young adults

You may be able to join this trial if you:


Your child: 
  •  Is 2 – 25 years old 
  •  Has SCD that doctors consider severe
  •  Has a brother of sister who is a full match to them and is able to be their donor 
You agree to have other standard tests done to see if your child can be in the clinical trial

Trial Details


Alemtuzumab is a monoclonal antibody that targets CD52 on certain cells.
Sirolimus is a drug that slows down the immune system.

Before transplant, your child will get the SUN regimen to prepare their body for BMT. This includes: 
  • Alemtuzumab – Given as intravenous (IV) infusions 5 times during the week before BMT
  • Sirolimus – Given as a pill your child takes by mouth 1 time the day before BMT 
  • Total Body Irradiation (TBI) – A treatment done 1 time 2 days before BMT to prepare your child’s body for transplant. In this trial, your child will get low dose TBI

On transplant day, the blood-forming cells from your child’s donor are given to them through an IV infusion.

After transplant, your child will get treatment to help prevent graft-versus-host-disease (GVHD):
  • Sirolimus – A pill that your child takes by mouth 1 time each day starting on the day of BMT 

Your child may continue treatment with sirolimus for up to 1 year. After BMT, the clinical trial doctors will check your child’s health for about 3 months. 

The Food and Drug Administration (FDA) has approved the drugs used in this trial. Using the SUN regimen before allogeneic BMT to treat SCD in children, teens and young adults is new and unproven.

Contacts


Robert Nickel, MD, 202-476-5000, RNickel@childrensnational.org

Fahmida Hoq, MBBS, 202-476-5000, fhoq@childrensnational.org

Locations

Children's National Health SystemRECRUITING

Washington D.C., District of Columbia
Contacts:

Ann & Robert H. Lurie Children's Hospital of ChicagoRECRUITING

Chicago, Illinois
Contacts:

Columbia UniversityRECRUITING

New York, New York
Jaclyn Dosik, 212-305-0866, jd3970@cumc.columbia.edu

Levine Children's HospitalRECRUITING

Charlotte, North Carolina
Janice Hollifield, 980-442-2342, Janice.hollifield@atriumhealth.org

Nationwide Children's HospitalRECRUITING

Columbus, Ohio
Hemalatha Rangarajan, 614-355-1689, Hemalatha.Rangarajan@nationwidechildrens.org

ClinicalTrials.gov record


NCT03587272. First posted on 7/16/18

Call center employee on the phone offering help to a caller

Questions? Contact our Clinical Trials Navigator

1-888-814-8610
contact@ctsearchsupport.org